Search Results - Edward C Keystone
- Showing 1 - 4 results of 4
-
1
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada by Mohammad Movahedi, Angela Cesta, Claire Bombardier, Edward C Keystone, Denis Choquette, Xiuying Li, Louis Coupal, OBRI Investigators
Published in BMJ Open (2023-03-01)Get full text
Article -
2
Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy. by Carole L Galligan, Janet C Siebert, Katherine A Siminovitch, Edward C Keystone, Vivian Bykerk, Omar D Perez, Eleanor N Fish
Published in PLoS ONE (2009-08-01)Get full text
Article -
3
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study by Boulos Haraoui, Majed Khraishi, Denis Choquette, Isabelle Fortin, Cassandra D. Kinch, Corina Galos, Patrice Roy, David Gruben, Julie Vaillancourt, John S. Sampalis, Edward C. Keystone
Published in Rheumatology and Therapy (2024-11-01)Get full text
Article -
4
A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort by Kathleen M. Andersen, Orit Schieir, Marie‐France Valois, Susan J. Bartlett, Louis Bessette, Gilles Boire, Boulos Haraoui, Glen Hazlewood, Carol Hitchon, Edward C. Keystone, Janet Pope, Diane Tin, J Carter Throne, Vivian P. Bykerk, CATCH Investigators
Published in ACR Open Rheumatology (2022-01-01)Get full text
Article
